SELLAS Life Sciences Group, Inc. (SLS)
Nasdaq: SLS · CIK 0001390478 · United States
Every official SELLAS Life Sciences Group, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open SLS filings
SELLAS Life Sciences Group, Inc. documents
- SELLAS Life Sciences Group, Inc. 10-K 2026SLS 10-K 2026: annual report for fiscal 2026
- SELLAS Life Sciences Group, Inc. 10-K 2025SLS 10-K 2025: annual report for fiscal 2025
- SELLAS Life Sciences Group, Inc. 10-K 2024SLS 10-K 2024: annual report for fiscal 2024
- SELLAS Life Sciences Group, Inc. 10-K 2023SLS 10-K 2023: annual report for fiscal 2023
- SELLAS Life Sciences Group, Inc. 10-K 2022SLS 10-K 2022: annual report for fiscal 2022
- SELLAS Life Sciences Group, Inc. 10-Q 2026SLS 10-Q 2026: quarterly report for fiscal 2026
- SELLAS Life Sciences Group, Inc. 10-Q 2025SLS 10-Q 2025: quarterly report for fiscal 2025
- SELLAS Life Sciences Group, Inc. 10-Q 2024SLS 10-Q 2024: quarterly report for fiscal 2024
- SELLAS Life Sciences Group, Inc. 10-Q 2023SLS 10-Q 2023: quarterly report for fiscal 2023
- SELLAS Life Sciences Group, Inc. 10-Q 2022SLS 10-Q 2022: quarterly report for fiscal 2022
- SELLAS Life Sciences Group, Inc. 8-K 2026SLS 8-K 2026: current report for fiscal 2026
- SELLAS Life Sciences Group, Inc. 8-K 2025SLS 8-K 2025: current report for fiscal 2025
- SELLAS Life Sciences Group, Inc. 8-K 2024SLS 8-K 2024: current report for fiscal 2024
- SELLAS Life Sciences Group, Inc. 8-K 2023SLS 8-K 2023: current report for fiscal 2023
- SELLAS Life Sciences Group, Inc. 8-K 2022SLS 8-K 2022: current report for fiscal 2022
- SELLAS Life Sciences Group, Inc. DEF 14A 2026SLS DEF 14A 2026: proxy statement for fiscal 2026
- SELLAS Life Sciences Group, Inc. DEF 14A 2025SLS DEF 14A 2025: proxy statement for fiscal 2025
- SELLAS Life Sciences Group, Inc. DEF 14A 2024SLS DEF 14A 2024: proxy statement for fiscal 2024
- SELLAS Life Sciences Group, Inc. DEF 14A 2023SLS DEF 14A 2023: proxy statement for fiscal 2023
- SELLAS Life Sciences Group, Inc. DEF 14A 2022SLS DEF 14A 2022: proxy statement for fiscal 2022
- SELLAS Life Sciences Group, Inc. Form 4 2026SLS Form 4 2026: insider trading filing for fiscal 2026
- SELLAS Life Sciences Group, Inc. Form 4 2025SLS Form 4 2025: insider trading filing for fiscal 2025
- SELLAS Life Sciences Group, Inc. Form 4 2024SLS Form 4 2024: insider trading filing for fiscal 2024
- SELLAS Life Sciences Group, Inc. Form 4 2023SLS Form 4 2023: insider trading filing for fiscal 2023
- SELLAS Life Sciences Group, Inc. Form 4 2022SLS Form 4 2022: insider trading filing for fiscal 2022
- SELLAS Life Sciences Group, Inc. S-1 2026SLS S-1 2026: registration statement for fiscal 2026
- SELLAS Life Sciences Group, Inc. S-1 2025SLS S-1 2025: registration statement for fiscal 2025
- SELLAS Life Sciences Group, Inc. S-1 2024SLS S-1 2024: registration statement for fiscal 2024
- SELLAS Life Sciences Group, Inc. S-1 2023SLS S-1 2023: registration statement for fiscal 2023
- SELLAS Life Sciences Group, Inc. S-1 2022SLS S-1 2022: registration statement for fiscal 2022
- SELLAS Life Sciences Group, Inc. 13F 2026SLS 13F 2026: institutional holdings for fiscal 2026
- SELLAS Life Sciences Group, Inc. 13F 2025SLS 13F 2025: institutional holdings for fiscal 2025
- SELLAS Life Sciences Group, Inc. 13F 2024SLS 13F 2024: institutional holdings for fiscal 2024
- SELLAS Life Sciences Group, Inc. 13F 2023SLS 13F 2023: institutional holdings for fiscal 2023
- SELLAS Life Sciences Group, Inc. 13F 2022SLS 13F 2022: institutional holdings for fiscal 2022
More companies